+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Glucose Monitoring Devices Market Research Report by Type (Diabetes Monitoring Devices and Insulin Delivery Devices), Application, End User, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • ID: 5532692
  • Report
  • April 2022
  • Region: Global
  • 192 Pages
  • 360iResearch™
UP TO OFF until Dec 31st 2022

FEATURED COMPANIES

  • AstraZeneca plc
  • Becton
  • GE Healthcare
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Philips Healthcare
The Global Glucose Monitoring Devices Market size was estimated at USD 5,900.86 million in 2021, USD 6,594.81 million in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 12.01% to reach USD 11,656.60 million by 2027.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Glucose Monitoring Devices to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Type, the market was studied across Diabetes Monitoring Devices and Insulin Delivery Devices. The Diabetes Monitoring Devices is further studied across Continuous Glucose Monitoring Devices, Glucose Meter, Glucose Test Strips, and Lancets and Lancing Devices. The Insulin Delivery Devices is further studied across Insulin Pens, Insulin Pumps, and Insulin Syringes.
  • Based on Application, the market was studied across Gestational Diabetes, Type 1 Diabetes, and Type 2 Diabetes.
  • Based on End User, the market was studied across Diagnostics, Home Settings, and Hospitals.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.

This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Glucose Monitoring Devices market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Glucose Monitoring Devices Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Glucose Monitoring Devices Market, including AstraZeneca plc, B. Braun Melsungen AG, Bayer HealthCare AG, Becton, DexCom, Inc., Dickinson & Company, GE Healthcare, GlaxoSmithKline plc, Insulet Corporation, Johnson & Johnson, Lupin Limited, Medtronic, Inc., Merck & Co., Inc., Nova Biomedical Corporation, Novartis International AG, Omron Healthcare, Philips Healthcare, ResMed Inc., Roche, Senseonics, and Takeda Pharmaceutical Company Limited.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Glucose Monitoring Devices Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Glucose Monitoring Devices Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Glucose Monitoring Devices Market?
4. What is the competitive strategic window for opportunities in the Global Glucose Monitoring Devices Market?
5. What are the technology trends and regulatory frameworks in the Global Glucose Monitoring Devices Market?
6. What is the market share of the leading vendors in the Global Glucose Monitoring Devices Market?
7. What modes and strategic moves are considered suitable for entering the Global Glucose Monitoring Devices Market?
Frequently Asked Questions about the Global Glucose Monitoring Devices Market

What is the estimated value of the Global Glucose Monitoring Devices Market?

The Global Glucose Monitoring Devices Market was estimated to be valued at $5900.9 Million in 2021.

What is the growth rate of the Global Glucose Monitoring Devices Market?

The growth rate of the Global Glucose Monitoring Devices Market is 12.0%, with an estimated value of $11656.6 Million by 2027.

What is the forecasted size of the Global Glucose Monitoring Devices Market?

The Global Glucose Monitoring Devices Market is estimated to be worth $11656.6 Million by 2027.

Who are the key companies in the Global Glucose Monitoring Devices Market?

Key companies in the Global Glucose Monitoring Devices Market include AstraZeneca plc, B. Braun Melsungen AG, Bayer HealthCare AG, Becton, DexCom, Inc., Dickinson & Company, GE Healthcare, GlaxoSmithKline plc and Johnson & Johnson.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • AstraZeneca plc
  • Becton
  • GE Healthcare
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Philips Healthcare

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Chronic illness including blood pressure, diabetes asthma and cardiovascular diseases require regular and continuous monitoring for a lifetime
5.1.1.2. Constant improvements in the self-monitoring blood glucose (SMBG) devices and point of caring testing (POCT) devices
5.1.1.3. Increasing demand for home-based treatment and self-medication to manage irregular chronic and acute illnesses
5.1.2. Restraints
5.1.2.1. Unfavourable reimbursement policies
5.1.3. Opportunities
5.1.3.1. Technological advancements and excessive research & development
5.1.3.2. Poor dietary habits, sedentary lifestyle, and development of new technologies
5.1.4. Challenges
5.1.4.1. Lack of standardization
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of 2022 Russia Ukraine Conflict
6. Glucose Monitoring Devices Market, by Type
6.1. Introduction
6.2. Diabetes Monitoring Devices
6.2.1. Continuous Glucose Monitoring Devices
6.2.2. Glucose Meter
6.2.3. Glucose Test Strips
6.2.4. Lancets and Lancing Devices
6.3. Insulin Delivery Devices
6.3.1. Insulin Pens
6.3.2. Insulin Pumps
6.3.3. Insulin Syringes
7. Glucose Monitoring Devices Market, by Application
7.1. Introduction
7.2. Gestational Diabetes
7.3. Type 1 Diabetes
7.4. Type 2 Diabetes
8. Glucose Monitoring Devices Market, by End User
8.1. Introduction
8.2. Diagnostics
8.3. Home Settings
8.4. Hospitals
9. Americas Glucose Monitoring Devices Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Glucose Monitoring Devices Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
11. Europe, Middle East & Africa Glucose Monitoring Devices Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. AstraZeneca plc
13.2. B. Braun Melsungen AG
13.3. Bayer HealthCare AG
13.4. Becton
13.5. DexCom, Inc.
13.6. Dickinson & Company
13.7. GE Healthcare
13.8. GlaxoSmithKline plc
13.9. Insulet Corporation
13.10. Johnson & Johnson
13.11. Lupin Limited
13.12. Medtronic, Inc.
13.13. Merck & Co., Inc.
13.14. Nova Biomedical Corporation
13.15. Novartis International AG
13.16. Omron Healthcare
13.17. Philips Healthcare
13.18. ResMed Inc.
13.19. Roche
13.20. Senseonics
13.21. Takeda Pharmaceutical Company Limited
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL GLUCOSE MONITORING DEVICES MARKET: DYNAMICS
FIGURE 2. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE, 2021 VS 2027 (%)
FIGURE 3. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 4. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE, 2027
FIGURE 5. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY DIABETES MONITORING DEVICES, 2019-2027 (USD MILLION)
FIGURE 6. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY DIABETES MONITORING DEVICES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 7. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2019-2027 (USD MILLION)
FIGURE 8. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 9. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY GLUCOSE METER, 2019-2027 (USD MILLION)
FIGURE 10. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY GLUCOSE METER, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 11. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY GLUCOSE TEST STRIPS, 2019-2027 (USD MILLION)
FIGURE 12. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY GLUCOSE TEST STRIPS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 13. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY LANCETS AND LANCING DEVICES, 2019-2027 (USD MILLION)
FIGURE 14. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY LANCETS AND LANCING DEVICES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 15. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2019-2027 (USD MILLION)
FIGURE 16. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 17. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN PENS, 2019-2027 (USD MILLION)
FIGURE 18. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN PENS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 19. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN PUMPS, 2019-2027 (USD MILLION)
FIGURE 20. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN PUMPS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 21. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN SYRINGES, 2019-2027 (USD MILLION)
FIGURE 22. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN SYRINGES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 23. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2021 VS 2027 (%)
FIGURE 24. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2021 VS 2027 (USD MILLION)
FIGURE 25. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2027
FIGURE 26. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY GESTATIONAL DIABETES, 2019-2027 (USD MILLION)
FIGURE 27. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY GESTATIONAL DIABETES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 28. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE 1 DIABETES, 2019-2027 (USD MILLION)
FIGURE 29. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 30. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE 2 DIABETES, 2019-2027 (USD MILLION)
FIGURE 31. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 32. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY END USER, 2021 VS 2027 (%)
FIGURE 33. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY END USER, 2021 VS 2027 (USD MILLION)
FIGURE 34. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY END USER, 2027
FIGURE 35. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY DIAGNOSTICS, 2019-2027 (USD MILLION)
FIGURE 36. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 37. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY HOME SETTINGS, 2019-2027 (USD MILLION)
FIGURE 38. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY HOME SETTINGS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 39. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY HOSPITALS, 2019-2027 (USD MILLION)
FIGURE 40. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 41. AMERICAS GLUCOSE MONITORING DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 42. ARGENTINA GLUCOSE MONITORING DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 43. BRAZIL GLUCOSE MONITORING DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 44. CANADA GLUCOSE MONITORING DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 45. MEXICO GLUCOSE MONITORING DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 46. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 47. ASIA-PACIFIC GLUCOSE MONITORING DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 48. AUSTRALIA GLUCOSE MONITORING DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 49. CHINA GLUCOSE MONITORING DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 50. INDIA GLUCOSE MONITORING DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 51. INDONESIA GLUCOSE MONITORING DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 52. JAPAN GLUCOSE MONITORING DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 53. MALAYSIA GLUCOSE MONITORING DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 54. PHILIPPINES GLUCOSE MONITORING DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 55. SINGAPORE GLUCOSE MONITORING DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 56. SOUTH KOREA GLUCOSE MONITORING DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 57. TAIWAN GLUCOSE MONITORING DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 58. THAILAND GLUCOSE MONITORING DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 59. EUROPE, MIDDLE EAST & AFRICA GLUCOSE MONITORING DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 60. FRANCE GLUCOSE MONITORING DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 61. GERMANY GLUCOSE MONITORING DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 62. ITALY GLUCOSE MONITORING DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 63. NETHERLANDS GLUCOSE MONITORING DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 64. QATAR GLUCOSE MONITORING DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 65. RUSSIA GLUCOSE MONITORING DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 66. SAUDI ARABIA GLUCOSE MONITORING DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 67. SOUTH AFRICA GLUCOSE MONITORING DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 68. SPAIN GLUCOSE MONITORING DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 69. UNITED ARAB EMIRATES GLUCOSE MONITORING DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 70. UNITED KINGDOM GLUCOSE MONITORING DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 71. GLOBAL GLUCOSE MONITORING DEVICES MARKET: FPNV POSITIONING MATRIX
FIGURE 72. GLOBAL GLUCOSE MONITORING DEVICES MARKET: SHARE, BY KEY PLAYER, 2021
FIGURE 73. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL GLUCOSE MONITORING DEVICES MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL GLUCOSE MONITORING DEVICES MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 4. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY DIABETES MONITORING DEVICES, BY REGION, 2019-2027 (USD MILLION)
TABLE 5. AMERICAS GLUCOSE MONITORING DEVICES MARKET SIZE, BY DIABETES MONITORING DEVICES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 6. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY DIABETES MONITORING DEVICES, BY STATE, 2019-2027 (USD MILLION)
TABLE 7. ASIA-PACIFIC GLUCOSE MONITORING DEVICES MARKET SIZE, BY DIABETES MONITORING DEVICES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 8. EUROPE, MIDDLE EAST & AFRICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY DIABETES MONITORING DEVICES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 9. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, BY REGION, 2019-2027 (USD MILLION)
TABLE 10. AMERICAS GLUCOSE MONITORING DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 11. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, BY STATE, 2019-2027 (USD MILLION)
TABLE 12. ASIA-PACIFIC GLUCOSE MONITORING DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 13. EUROPE, MIDDLE EAST & AFRICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 14. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY GLUCOSE METER, BY REGION, 2019-2027 (USD MILLION)
TABLE 15. AMERICAS GLUCOSE MONITORING DEVICES MARKET SIZE, BY GLUCOSE METER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 16. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY GLUCOSE METER, BY STATE, 2019-2027 (USD MILLION)
TABLE 17. ASIA-PACIFIC GLUCOSE MONITORING DEVICES MARKET SIZE, BY GLUCOSE METER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 18. EUROPE, MIDDLE EAST & AFRICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY GLUCOSE METER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 19. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY GLUCOSE TEST STRIPS, BY REGION, 2019-2027 (USD MILLION)
TABLE 20. AMERICAS GLUCOSE MONITORING DEVICES MARKET SIZE, BY GLUCOSE TEST STRIPS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 21. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY GLUCOSE TEST STRIPS, BY STATE, 2019-2027 (USD MILLION)
TABLE 22. ASIA-PACIFIC GLUCOSE MONITORING DEVICES MARKET SIZE, BY GLUCOSE TEST STRIPS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 23. EUROPE, MIDDLE EAST & AFRICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY GLUCOSE TEST STRIPS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 24. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY LANCETS AND LANCING DEVICES, BY REGION, 2019-2027 (USD MILLION)
TABLE 25. AMERICAS GLUCOSE MONITORING DEVICES MARKET SIZE, BY LANCETS AND LANCING DEVICES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 26. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY LANCETS AND LANCING DEVICES, BY STATE, 2019-2027 (USD MILLION)
TABLE 27. ASIA-PACIFIC GLUCOSE MONITORING DEVICES MARKET SIZE, BY LANCETS AND LANCING DEVICES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 28. EUROPE, MIDDLE EAST & AFRICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY LANCETS AND LANCING DEVICES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 29. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, BY REGION, 2019-2027 (USD MILLION)
TABLE 30. AMERICAS GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 31. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, BY STATE, 2019-2027 (USD MILLION)
TABLE 32. ASIA-PACIFIC GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 33. EUROPE, MIDDLE EAST & AFRICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 34. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN PENS, BY REGION, 2019-2027 (USD MILLION)
TABLE 35. AMERICAS GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN PENS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 36. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN PENS, BY STATE, 2019-2027 (USD MILLION)
TABLE 37. ASIA-PACIFIC GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN PENS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 38. EUROPE, MIDDLE EAST & AFRICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN PENS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 39. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN PUMPS, BY REGION, 2019-2027 (USD MILLION)
TABLE 40. AMERICAS GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN PUMPS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 41. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN PUMPS, BY STATE, 2019-2027 (USD MILLION)
TABLE 42. ASIA-PACIFIC GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN PUMPS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 43. EUROPE, MIDDLE EAST & AFRICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN PUMPS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 44. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN SYRINGES, BY REGION, 2019-2027 (USD MILLION)
TABLE 45. AMERICAS GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN SYRINGES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 46. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN SYRINGES, BY STATE, 2019-2027 (USD MILLION)
TABLE 47. ASIA-PACIFIC GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN SYRINGES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 48. EUROPE, MIDDLE EAST & AFRICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN SYRINGES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 49. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 50. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY GESTATIONAL DIABETES, BY REGION, 2019-2027 (USD MILLION)
TABLE 51. AMERICAS GLUCOSE MONITORING DEVICES MARKET SIZE, BY GESTATIONAL DIABETES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 52. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY GESTATIONAL DIABETES, BY STATE, 2019-2027 (USD MILLION)
TABLE 53. ASIA-PACIFIC GLUCOSE MONITORING DEVICES MARKET SIZE, BY GESTATIONAL DIABETES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 54. EUROPE, MIDDLE EAST & AFRICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY GESTATIONAL DIABETES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 55. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2019-2027 (USD MILLION)
TABLE 56. AMERICAS GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE 1 DIABETES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 57. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE 1 DIABETES, BY STATE, 2019-2027 (USD MILLION)
TABLE 58. ASIA-PACIFIC GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE 1 DIABETES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 59. EUROPE, MIDDLE EAST & AFRICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE 1 DIABETES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 60. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2019-2027 (USD MILLION)
TABLE 61. AMERICAS GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE 2 DIABETES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 62. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE 2 DIABETES, BY STATE, 2019-2027 (USD MILLION)
TABLE 63. ASIA-PACIFIC GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE 2 DIABETES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 64. EUROPE, MIDDLE EAST & AFRICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE 2 DIABETES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 65. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 66. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2019-2027 (USD MILLION)
TABLE 67. AMERICAS GLUCOSE MONITORING DEVICES MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 68. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY DIAGNOSTICS, BY STATE, 2019-2027 (USD MILLION)
TABLE 69. ASIA-PACIFIC GLUCOSE MONITORING DEVICES MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 70. EUROPE, MIDDLE EAST & AFRICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 71. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY HOME SETTINGS, BY REGION, 2019-2027 (USD MILLION)
TABLE 72. AMERICAS GLUCOSE MONITORING DEVICES MARKET SIZE, BY HOME SETTINGS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 73. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY HOME SETTINGS, BY STATE, 2019-2027 (USD MILLION)
TABLE 74. ASIA-PACIFIC GLUCOSE MONITORING DEVICES MARKET SIZE, BY HOME SETTINGS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 75. EUROPE, MIDDLE EAST & AFRICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY HOME SETTINGS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 76. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2019-2027 (USD MILLION)
TABLE 77. AMERICAS GLUCOSE MONITORING DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 78. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY HOSPITALS, BY STATE, 2019-2027 (USD MILLION)
TABLE 79. ASIA-PACIFIC GLUCOSE MONITORING DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 81. AMERICAS GLUCOSE MONITORING DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 82. ARGENTINA GLUCOSE MONITORING DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 83. BRAZIL GLUCOSE MONITORING DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 84. CANADA GLUCOSE MONITORING DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 85. MEXICO GLUCOSE MONITORING DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 86. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 87. ASIA-PACIFIC GLUCOSE MONITORING DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 88. AUSTRALIA GLUCOSE MONITORING DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 89. CHINA GLUCOSE MONITORING DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 90. INDIA GLUCOSE MONITORING DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 91. INDONESIA GLUCOSE MONITORING DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 92. JAPAN GLUCOSE MONITORING DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 93. MALAYSIA GLUCOSE MONITORING DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 94. PHILIPPINES GLUCOSE MONITORING DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 95. SINGAPORE GLUCOSE MONITORING DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 96. SOUTH KOREA GLUCOSE MONITORING DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 97. TAIWAN GLUCOSE MONITORING DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 98. THAILAND GLUCOSE MONITORING DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA GLUCOSE MONITORING DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 100. FRANCE GLUCOSE MONITORING DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 101. GERMANY GLUCOSE MONITORING DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 102. ITALY GLUCOSE MONITORING DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 103. NETHERLANDS GLUCOSE MONITORING DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 104. QATAR GLUCOSE MONITORING DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 105. RUSSIA GLUCOSE MONITORING DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 106. SAUDI ARABIA GLUCOSE MONITORING DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 107. SOUTH AFRICA GLUCOSE MONITORING DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 108. SPAIN GLUCOSE MONITORING DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 109. UNITED ARAB EMIRATES GLUCOSE MONITORING DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 110. UNITED KINGDOM GLUCOSE MONITORING DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 111. GLOBAL GLUCOSE MONITORING DEVICES MARKET: SCORES
TABLE 112. GLOBAL GLUCOSE MONITORING DEVICES MARKET: BUSINESS STRATEGY
TABLE 113. GLOBAL GLUCOSE MONITORING DEVICES MARKET: PRODUCT SATISFACTION
TABLE 114. GLOBAL GLUCOSE MONITORING DEVICES MARKET: RANKING
TABLE 115. GLOBAL GLUCOSE MONITORING DEVICES MARKET: SHARE, BY KEY PLAYER, 2021
TABLE 116. GLOBAL GLUCOSE MONITORING DEVICES MARKET: MERGER & ACQUISITION
TABLE 117. GLOBAL GLUCOSE MONITORING DEVICES MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 118. GLOBAL GLUCOSE MONITORING DEVICES MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 119. GLOBAL GLUCOSE MONITORING DEVICES MARKET: INVESTMENT & FUNDING
TABLE 120. GLOBAL GLUCOSE MONITORING DEVICES MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 121. GLOBAL GLUCOSE MONITORING DEVICES MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • AstraZeneca plc
  • B. Braun Melsungen AG
  • Bayer HealthCare AG
  • Becton
  • DexCom, Inc.
  • Dickinson & Company
  • GE Healthcare
  • GlaxoSmithKline plc
  • Insulet Corporation
  • Johnson & Johnson
  • Lupin Limited
  • Medtronic, Inc.
  • Merck & Co., Inc.
  • Nova Biomedical Corporation
  • Novartis International AG
  • Omron Healthcare
  • Philips Healthcare
  • ResMed Inc.
  • Roche
  • Senseonics
  • Takeda Pharmaceutical Company Limited
Note: Product cover images may vary from those shown

Loading
LOADING...